Brachytherapy and ocular melanomas. Ocular melanoma, though rare relative to all other cancers, is the most common type of eye cancer in adults. Plaque brachytherapy treatments deliver radiation to ...

IDEAYA said that for the enucleation cohort, the randomisation will be with or without darovasertib as neoadjuvant therapy; and for the plaque brachytherapy cohort, the randomisation will be ...

ARVO 2012: Early diagnosis of radiation retinopathy after plaque brachytherapy, followed by prompt treatment with intravitreal bevacizumab, may prevent vision loss in patients with uveal melanoma.

Bowen explained that there are three different treatment options for uveal melanoma. The most common treatment method is plaque brachytherapy, which involves inserting seeds of the radioactive ...

Plaque Brachytherapy is a sophisticated and localized radiation therapy for treatment of recurrent retinoblastoma, as it provides focused treatment of eye cancer without damaging the surrounding ...

Uveal Melanoma Treated With Iodine-125 Episcleral Plaque: An Analysis of Dose on Disease Control and Visual Outcomes . Perez BA, Mettu P, Vajzovic L, et al Int J Radiat Oncol Biol Phys. 2014;89: ...

ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and ...

Time to vision loss as the primary endpoint for plaque brachytherapy patients. No detriment to Event-Free-Survival (EFS) in the treatment arms is a secondary endpoint.

A 55-year-old white female presented to our clinics for a comprehensive eye examination. Her ocular history was significant for a choroidal nevus in the right eye and a choroidal melanoma in the ...

ATLANTA, March 19, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and ...